UNSPSC 85602530: Supplement right large intestine via natural or artificial opening autologous tissue substitute, via natural or artificial opening

This classification denotes the group of activities that yields a surgical intervention or procedure to supplement right large intestine via natural or artificial opening autologous tissue substitute, via natural or artificial opening. This surgical intervention or procedure is listed in the World Health Organization's International Statistical Classification of Diseases and Related Health Problems or ICD-10 as code 0DUF77Z

UNSPSC 85602530, Supplement right large intestine via natural or artificial opening autologous tissue substitute via natural or artificial opening, is a Commodity code that describes a specific surgical procedure, yet the recent state and local procurement activity tagged under this code does not reflect actual surgical implant or tissue-substitute procurement. Instead, the opportunities posted under this code span occupational health surveillance, independent medical evaluations, pharmacy benefit management, temporary health professional staffing, and specialty surgical benefits programs — none of which involve procurement of biological tissue substitutes or surgical devices for intestinal repair. The mismatch between the code's nominal scope and the work actually being solicited suggests that this code either has been misapplied by issuing bodies or reflects a data-classification artifact rather than active demand for the procedure itself.

No procurement activity in the source demonstrates demand for large intestine tissue-substitute implants or related surgical supplies. The Arizona Public Safety Personnel Retirement System sought independent medical evaluators to assess disability claims; the City of Long Beach and Washington State Ferries sought occupational and preventive health services; Harris County Juvenile Probation Department issued an RFI for emergency and specialty healthcare delivery; and Collier County and Santa Clara County Health System issued RFPs for pharmacy benefit management and temporary clinical staffing. None of these solicitations involve surgical device procurement, specialty pharmacy delivery of biologics specific to intestinal repair, or the product or service family that the code's name describes. Business development professionals should not pursue this code on the assumption that state and local governments are actively buying large intestine tissue substitutes; the recent activity provides no evidence of such demand.